An Act requiring informed consent for marijuana testing

HD 1697 requires healthcare facilities, physicians, and providers to obtain written informed consent before testing patients for marijuana or THC, sharing test results, or identifying the patient based on such tests. This applies directly to patients receiving medical care where marijuana testing might occur, ensuring they explicitly agree to each test and disclosure. The bill mandates that consent forms must state the specific purpose of the test or disclosure and be distinct from general medical consent forms. Violating these requirements would be treated as a violation of Chapter 93A (unfair business practices law). The policy change directly alters how healthcare providers handle marijuana-related testing and data privacy.